-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, B5ArywWX5dEWbR1tItCyfD7edpW/9qgBVSrCV4Yd3yAG57dSyOQGy2ux7JGziRJW gBRB06oTfG9GO3W8ozGa4A== 0001144204-07-015407.txt : 20070330 0001144204-07-015407.hdr.sgml : 20070330 20070330090014 ACCESSION NUMBER: 0001144204-07-015407 CONFORMED SUBMISSION TYPE: NT 10-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061231 FILED AS OF DATE: 20070330 DATE AS OF CHANGE: 20070330 EFFECTIVENESS DATE: 20070330 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lab123, Inc. CENTRAL INDEX KEY: 0001375772 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 450542515 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-137545 FILM NUMBER: 07729473 BUSINESS ADDRESS: STREET 1: 233 NARRAGANSETT AVENUE CITY: LAWRENCE STATE: NY ZIP: 11559 BUSINESS PHONE: 516-837-9876 MAIL ADDRESS: STREET 1: 233 NARRAGANSETT AVENUE CITY: LAWRENCE STATE: NY ZIP: 11559 NT 10-K 1 v069860_nt-10k.htm Unassociated Document
SEC File Number: 333-137545

      CUSIP Number: None


U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR
o Form N-CSR

For Period Ended:  December 31, 2006

o Transition Report on Form 10-K
o Transition Report on Form 20-F
o Transition Report on Form 11-K
o Transition Report on Form 10-Q
o Transition Report on Form N-SAR

For the Transition Period Ended:

 
Read Instruction(on back page) Before Preparing form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: 


 
Part I - Registrant Information

 
Full Name of Registrant:   Lab123, Inc.
Former Name if Applicable:  Not applicable.
 
 
Address of Principal Executive Office:

100 Field Drive, Suite 240
Lake Forest, Illinois 60045

(Street and Number, City, State and Zip Code)
 
 
 
 
 
Part II - Rules 12b-25(b) and (c)
 
 
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

x  (a)  The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
 
x  (b)  The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
 
o  (c)  The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 
Part III - Narrative

 
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof could not be filed within the prescribed period.
(Attach Extra Sheets if Needed)

The registrant is unable to file its Annual Report on Form 10-KSB for the fiscal year ended December 31, 2006 (the “Report”) by the prescribed date of April 2, 2007 without unreasonable effort or expense because its internal accountants need additional time to complete portions of the Report. The registrant intends to file its Report on or prior to the prescribed extended date.
 
 
Part IV - Other Information

 
1.  Name and telephone number of person to contact in regard to this notification:
 
  Henry Warner   847-234-8111
     
  (Name) (Area Code) (Telephone Number)
 
2.  Have all other periodic reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed. If the answer is no, Identify report(s).

x Yes  o No
 
 
 
 
 
 
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

o Yes  x No
 
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
 
 
 Lab123, Inc. 
 (Name of Registrant as specified in charter)
 
has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

 
     
   
 
 		  
 		  
 
Date: March 30, 2007 By:   /s/ Henry Warner
 
 
Henry Warner
Chairman of the Board
 

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.





 -----END PRIVACY-ENHANCED MESSAGE-----